Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment

Glioblastoma (GBM) is the most common and devastating primary brain tumor, leading to a uniform fatality after diagnosis. A major difficulty in eradicating GBM is the presence of microscopic residual infiltrating disease remaining after multimodality treatment. Glioma cancer stem cells (CSCs) have b...

Full description

Bibliographic Details
Main Authors: Henry Ruiz-Garcia, Keila Alvarado-Estrada, Paula Schiapparelli, Alfredo Quinones-Hinojosa, Daniel M. Trifiletti
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fncel.2020.558381/full
_version_ 1818382228093140992
author Henry Ruiz-Garcia
Henry Ruiz-Garcia
Keila Alvarado-Estrada
Paula Schiapparelli
Alfredo Quinones-Hinojosa
Daniel M. Trifiletti
Daniel M. Trifiletti
author_facet Henry Ruiz-Garcia
Henry Ruiz-Garcia
Keila Alvarado-Estrada
Paula Schiapparelli
Alfredo Quinones-Hinojosa
Daniel M. Trifiletti
Daniel M. Trifiletti
author_sort Henry Ruiz-Garcia
collection DOAJ
description Glioblastoma (GBM) is the most common and devastating primary brain tumor, leading to a uniform fatality after diagnosis. A major difficulty in eradicating GBM is the presence of microscopic residual infiltrating disease remaining after multimodality treatment. Glioma cancer stem cells (CSCs) have been pinpointed as the treatment-resistant tumor component that seeds ultimate tumor progression. Despite the key role of CSCs, the ideal preclinical model to study the genetic and epigenetic landmarks driving their malignant behavior while simulating an accurate interaction with the tumor microenvironment (TME) is still missing. The introduction of three-dimensional (3D) tumor platforms, such as organoids and 3D bioprinting, has allowed for a better representation of the pathophysiologic interactions between glioma CSCs and the TME. Thus, these technologies have enabled a more detailed study of glioma biology, tumor angiogenesis, treatment resistance, and even performing high-throughput screening assays of drug susceptibility. First, we will review the foundation of glioma biology and biomechanics of the TME, and then the most up-to-date insights about the applicability of these new tools in malignant glioma research.
first_indexed 2024-12-14T02:47:08Z
format Article
id doaj.art-ee534fba05924a8e8f6bd0e5b5fc5a3b
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-12-14T02:47:08Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-ee534fba05924a8e8f6bd0e5b5fc5a3b2022-12-21T23:19:51ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022020-10-011410.3389/fncel.2020.558381558381Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor MicroenvironmentHenry Ruiz-Garcia0Henry Ruiz-Garcia1Keila Alvarado-Estrada2Paula Schiapparelli3Alfredo Quinones-Hinojosa4Daniel M. Trifiletti5Daniel M. Trifiletti6Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Radiation Oncology, Mayo Clinic, Jacksonville, FL, United StatesDepartment of Neurological Surgery, Mayo Clinic, Jacksonville, FL, United StatesGlioblastoma (GBM) is the most common and devastating primary brain tumor, leading to a uniform fatality after diagnosis. A major difficulty in eradicating GBM is the presence of microscopic residual infiltrating disease remaining after multimodality treatment. Glioma cancer stem cells (CSCs) have been pinpointed as the treatment-resistant tumor component that seeds ultimate tumor progression. Despite the key role of CSCs, the ideal preclinical model to study the genetic and epigenetic landmarks driving their malignant behavior while simulating an accurate interaction with the tumor microenvironment (TME) is still missing. The introduction of three-dimensional (3D) tumor platforms, such as organoids and 3D bioprinting, has allowed for a better representation of the pathophysiologic interactions between glioma CSCs and the TME. Thus, these technologies have enabled a more detailed study of glioma biology, tumor angiogenesis, treatment resistance, and even performing high-throughput screening assays of drug susceptibility. First, we will review the foundation of glioma biology and biomechanics of the TME, and then the most up-to-date insights about the applicability of these new tools in malignant glioma research.https://www.frontiersin.org/article/10.3389/fncel.2020.558381/fullgliomatumor microenvironmentstem cellbioprintingorganoidsorgan-on-a-chip
spellingShingle Henry Ruiz-Garcia
Henry Ruiz-Garcia
Keila Alvarado-Estrada
Paula Schiapparelli
Alfredo Quinones-Hinojosa
Daniel M. Trifiletti
Daniel M. Trifiletti
Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
Frontiers in Cellular Neuroscience
glioma
tumor microenvironment
stem cell
bioprinting
organoids
organ-on-a-chip
title Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
title_full Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
title_fullStr Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
title_full_unstemmed Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
title_short Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
title_sort engineering three dimensional tumor models to study glioma cancer stem cells and tumor microenvironment
topic glioma
tumor microenvironment
stem cell
bioprinting
organoids
organ-on-a-chip
url https://www.frontiersin.org/article/10.3389/fncel.2020.558381/full
work_keys_str_mv AT henryruizgarcia engineeringthreedimensionaltumormodelstostudygliomacancerstemcellsandtumormicroenvironment
AT henryruizgarcia engineeringthreedimensionaltumormodelstostudygliomacancerstemcellsandtumormicroenvironment
AT keilaalvaradoestrada engineeringthreedimensionaltumormodelstostudygliomacancerstemcellsandtumormicroenvironment
AT paulaschiapparelli engineeringthreedimensionaltumormodelstostudygliomacancerstemcellsandtumormicroenvironment
AT alfredoquinoneshinojosa engineeringthreedimensionaltumormodelstostudygliomacancerstemcellsandtumormicroenvironment
AT danielmtrifiletti engineeringthreedimensionaltumormodelstostudygliomacancerstemcellsandtumormicroenvironment
AT danielmtrifiletti engineeringthreedimensionaltumormodelstostudygliomacancerstemcellsandtumormicroenvironment